Metabolic clearance rates and secretion rates of prolactin in sheep

Insulin metabolism and its effect on blood electrolytes and glucose in the turkey hen

Insulin half-life (T1/2) was determined to be similar between egg-laying and non-laying turkey hens, averaging 7.5 vs 8.7 min, respectively. Infused insulin lowered plasma glucose 25% in both groups although the time course of each response was different. Circulating phosphorous decreased 30 min following insulin treatment and returned to preinjection concentrations at the end of sampling. Insulin initiated immediate decreases in plasma calcium and magnesium. It is evident that insulin is involved in electrolyte metabolism as well as glucose metabolism in birds.

Continuous elevation of blood growth hormone concentrations by beeswax implant

We examined constancy of release of purified ovine growth hormone from an implant containing soybean oil and beeswax. Implants contained an amount of growth hormone that was sufficient to increase concentrations in blood plasma by 20 and 40 ng/ml and to maintain those concentrations over 1 wk. Growth hormone in plasma increased to approximately 65 ng/ml in lambs receiving low dose implants the 1st day after implantation, returned to 31 ng/ml on day 2, and remained near this concentration for the remainder of the week. Pulse release of growth hormone was not similiar in the high dose lambs where growth hormone concentration in plasma averaged 45 ng/ml 1 day after implantation, then gradually increased to 60 ng/ml on day 6. Unimplanted control lambs had mean growth hormone concentrations of 2.9 to 3.9 ng/ml throughout the 6-day observation. This approach should interest investigators studying the chronic influence of purified or synthetic growth hormone on dairy cows, beef steers, or lambs.

Effects of cranial cervical ganglionectomy and castration of male lambs. II. 24 hour plasma profiles of luteinizing hormone, testosterone and prolactin

Male lambs were utilized in an experiment designed to evaluate the effects of cranial cervical ganglionectomy (GX), castration and age on hormone secretion profiles. Blood plasma samples were collected at hourly intervals for 24 hours from 24 lambs aged 101 days and 20 lambs aged 277 days, then assayed for concentrations of luteinizing hormone (LH), testosterone and prolactin. At both ages pulsatile secretion of LH and testosterone was confirmed, but no circadian rhythm of LH testosterone or prolactin secretion was detected. Castration elevated LH levels significantly at both ages. GX and its interaction with castration had no effect on LH secretion at 101 days, but at 277 days these factors were significant, largely due to elevated levels being recorded from GX castrates. GX did not affect testosterone levels in entire animals at either age, while plasma from castrates contained no detectable testosterone. GX reduced prolactin concentrations at 101 days of age (summer) but elevated them at 277 days of age (winter). Castration and the interaction of castration with GX had no significant influence on plasma prolactin levels at either age. This study confirmed that the pineal gland of sheep is involved in the regulation of prolactin secretion, and probably influences LH secretion as well.

Metabolic clearance and production rates of prolactin in man

Metabolic clearance rates (MCR) and production rates (PR) of prolactin (PRL) have been determined by the constant infusion to equilibrium technique in 11 normal subjects, 6 patients with hyperthyroidism, 4 patients with hypothyroidism, and 9 patients with hyperprolactinemia. PRL MCR was also determined tin four patients during dopamine infusion. Mean PRL MCR was 46 +/- 1 ml/min per m2 in women and 44 +/- 3 ml/min per m2 in men, and was significantly correlated with body mass (r = 0.84, P less than 0.001). In contrast with controls, PRL MCR was higher in hyperthyroidism (MCR = 52 +/- 8 ml/min per m2, P less than 0.05), was slightly lower in hypothyroidism (MCR = 38 +/- 10 ml/min per m2, P = NS), and was significantly correlated with serum thyroxine (r = 0.46, P less than 0.02). PRL MCR was lower than controls in hyperprolactinemia (MCR = 40 +/- 5 ml/min per m2, P less than 0.01) and was inversely correlated with serum PRL (r = -0.72, P less than 0.001). PRL MCR was not significantly changed by dopamine infusion. Mean PRL PR for women and men was 211 +/- 74 and 187 +/- 44 micrograms/d per m2, respectively (P = NS). In hyperthyroidism the PRL PR was elevated (PR = 335 +/- 68 micrograms/d per m2, P less than 0.02), but in hypothyroidism the increase (PR = 233 +/- 159 micrograms/d per m2) was not significant. In hyperprolactinemia the PRL PR was extremely high (PR = 31,000 +/- 29,000 micrograms/d per m2). Dopamine infusion decreased RPL PR from 270 to 66 micrograms/d per m2 indicating that its effect was on pituitary PRL secretion and not PRL metabolism. To evaluate possible circulating PRL heterogeneity that might arise during infusion, gel filtration of infusate and serum obtained during the MCR procedure was performed. Labeled monomeric PRL (peak III, Kav (partition coefficient) = 0.4) was partially converted to two larger forms (peaks I and II) in vivo. Peak I (Kav = 0) was 30--40% immunoprecipitable, although peak II (Kav = 0.2) was not immunoprecipitable. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of peak I resulted in greater than or equal to 90% conversion to peak III and restoration of full immunoactivity. Thus, peak I is a noncovalently linked aggregate that is partially immunoactive, and therefore able to alter MCR determinations. These studies demonstrate the impact of hormone heterogeneity on MCR estimations and suggest that gel filtration of immunoprecipitable material be an integral part of future MCR measurements.

Luteolysis, estrus and ovulation, and blood prostaglandin F after intramuscular administration of 15, 30 or 60 mg prostaglanding F2alpha

During diestrus in three consecutive estrous cycles, each of six heifers was given (im) 30 mg, 15 mg (twice at 6-hr intervals) and 60 mg prostaglandin F2alpha (PGF2alpha) tham salt. Neither the decline in blood progesterone, the increase in blood estradiol, the duration or the peak of the LH surge, the interval to onset of estrus, nor the interval to ovulation was affected significantly by dose of PGF2alpha. Thus, relative to that after 30 mg PGF2alpha im, two injections of 15 mg at 6-hr intervals or 60 mg PGF2alpha did not hasten luteolysis. Thirty mg was an ample in dose of PGF2alpha to cause luteolysis. Regardless of im dose of PGF2alpha, blood PGF peaked at about 6.0 ng/ml within 10 minutes and returned to basal values (less than 1.0 ng/ml) within 90 minutes. In another trial, after a single iv injection of 5 mg PGF2alpha, blood PGF peaked (25 ng/ml) within 5 minutes and returned to basal values within 15 minutes. During a 30-minute infusion (0.5 mg/minute) of PGF2alpha, blood PGF plateaued at 29.5 ng/ml with a metabolic clearance rate of 17.0 liters per minute.